BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4623041)

  • 21. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM; Vahrson HW; Freeman DA
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections.
    Bell RB; Aurelian L; Cohen GH
    Cell Immunol; 1978 Nov; 41(1):86-102. PubMed ID: 82488
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxic blocking activity in invasive squamous cell carcinoma of the human uterine cervix.
    Dini MM; Faiferman I
    Cancer; 1980 Dec; 46(12):2573-6. PubMed ID: 7448696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of protein-calorie malnutrition on immunoglobulin and complement levels in oesophageal carcinoma.
    Haffejee AA; Angorn IB; Hallett AF; Cooper R
    Clin Oncol; 1979 Jun; 5(2):115-22. PubMed ID: 111885
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumor-bound immunoglobulin in human gynecologic cancers.
    McCoy JP; Hofheinz DE; Ng AB; Nordqvist S; Haines HG
    J Natl Cancer Inst; 1979 Aug; 63(2):279-83. PubMed ID: 222928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular immunity in carcinoma of the uterine cervix].
    Pasqualini RS; Giraudo Conesa LC; Chevallier R
    Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
    [No Abstract]   [Full Text] [Related]  

  • 27. Human sera containing immunoglobulin and nonimmunoglobulin spermagglutinins.
    Boettcher B; Kay DJ; Rumke P; Wright LE
    Biol Reprod; 1971 Dec; 5(3):236-45. PubMed ID: 4130408
    [No Abstract]   [Full Text] [Related]  

  • 28. Partial characterization of serum suppressor factors in patients with cervical squamous carcinoma.
    Dini MM; Faiferman I
    Am J Reprod Immunol (1980); 1982 Aug; 2(4):199-203. PubMed ID: 7137444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix.
    Ngan HY; Chan SY; Wong LC; Choy DT; Ma HK
    Gynecol Oncol; 1990 May; 37(2):260-3. PubMed ID: 2344971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Circulating immunocomplexes in the serum of female patients suffering with cancer of the uterine cervix (author's transl)].
    Vodvárka P; Willaschek J; Lochman I; Vrtná L
    Cesk Gynekol; 1982 May; 47(4):272-8. PubMed ID: 7094057
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum immunoglobulin concentrations in sera of patients with carcinoma of the cervix.
    Adelusi B; Salimonu LS
    Gynecol Oncol; 1981 Feb; 11(1):75-81. PubMed ID: 7203165
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody cytotoxicity studies in ovarian and cervical malignancies.
    Disaia PJ; Nalick RH; Townsend DE
    Obstet Gynecol; 1973 Nov; 42(5):644-50. PubMed ID: 4796001
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum immunoglobulins in head & neck cancer: effect of radiotherapy.
    Kohli GS; Yadav SP; Chowdhry D; Mehta HC
    Indian J Cancer; 1987 Mar; 24(1):9-14. PubMed ID: 3428924
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serum IgG, IgA and IgM levels in cervical cancer patients].
    Noeva K; Iurukov K
    Acta Microbiol Virol Immunol (Sofiia); 1977; 5():59-64. PubMed ID: 416657
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody-dependent cell mediated cytotoxicity against nucleated target cells in patients with squamous cell carcinoma of uterine cervix.
    Bose M; Seth P; Pothen S; Sharma LK; Ghosh D
    Indian J Med Res; 1985 May; 81():488-92. PubMed ID: 4030033
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute phase reactants and complement components as indicators of recurrence in human cervical cancer.
    te Velde ER; Berrens L; Zegers BJ; Ballieux RE
    Eur J Cancer (1965); 1979 Jun; 15(6):893-9. PubMed ID: 499276
    [No Abstract]   [Full Text] [Related]  

  • 39. The immunofluorescence characteristics of the basement membrane in squamous carcinoma of the uterine cervix.
    Rubio CA; Biberfeld P; Einhorn N
    Histopathology; 1978 Jan; 2(1):67-73. PubMed ID: 352895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectopic human chorionic gonadotropin in carcinoma cervix.
    Dash RJ; Dutta TK; Gupta SK; Purohit OP; Jayakumar RV; Gupta BD
    Indian J Med Res; 1979 Sep; 70():478-82. PubMed ID: 535958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.